|
1
|
Tanaka M, Murakami K, Ozaki S, Imura Y,
Tong XP, Watanabe T, Sawaki T, Kawanami T, Kawabata D, Fujii T, et
al: DIP2 disco-interacting protein 2 homolog A (Drosophila) is a
candidate receptor for follistatin-related
protein/follistatin-like1-analysis of their binding with TGF-β
superfamily proteins. FEBS J. 277:4278–4289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan X, Ding JY, Zhang RJ, Zhang HQ, Kang
L, Jia CY, Liu XY and Shen CL: FSTL1 accelerates nucleus pulposus
cell senescence and intervertebral disc degeneration through
TLR4/NF-κB pathway. Inflammation. 47:1229–1247. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adams D, Larman B and Oxburgh L:
Developmental expression of mouse Follistatin-like 1 (Fstl1):
Dynamic regulation during organogenesis of the kidney and lung.
Gene Expr Patterns. 7:491–500. 2007. View Article : Google Scholar
|
|
4
|
Lara-Pezzi E, Felkin LE, Birks EJ,
Sarathchandra P, Panse KD, George R, Hall JL, Yacoub MH, Rosenthal
N and Barton PJ: Expression of Follistatin-related genes is altered
in heart failure. Endocrinology. 149:5822–5827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC
and Cheung AN: Tumor suppressor effect of follistatin-like 1 in
ovarian and endometrial carcinogenesis: A differential expression
and functional analysis. Carcinogenesis. 30:114–121. 2009.
View Article : Google Scholar
|
|
6
|
Chaly Y, Marinov AD, Oxburgh L, Bushnell
DS and Hirsch R: FSTL1 promotes arthritis in mice by enhancing
inflammatory cytokine/chemokine expression. Arthritis Rheum.
64:1082–1088. 2012. View Article : Google Scholar
|
|
7
|
Peters MC, Di Martino S, Boelens T, Qin J,
van Mil A, Doevendans PA, Chamuleau SAJ, Sluijter JPG and Neef K:
Follistatin-like 1 promotes proliferation of matured human hypoxic
iPSC-cardiomyocytes and is secreted by cardiac fibroblasts. Mol
Ther Methods Clin Dev. 25:3–16. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clutter SD, Wilson DC, Marinov AD and
Hirsch R: Follistatin-like protein 1 promotes arthritis by
up-regulating IFN-gamma. J Immunol. 182:234–239. 2009. View Article : Google Scholar
|
|
9
|
Kawabata D, Tanaka M, Fujii T, Umehara H,
Fujita Y, Yoshifuji H, Mimori T and Ozaki S: Ameliorative effects
of follistatin-related protein/TSC-36/FSTL1 on joint inflammation
in a mouse model of arthritis. Arthritis Rheum. 50:660–668. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Fang W, Hu Y, Wang Y and Li J:
Characterization of fibronectin type III domain-containing protein
5 (FNDC5) gene in chickens: Cloning, tissue expression, and
regulation of its expression in the muscle by fasting and cold
exposure. Gene. 570:221–229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu S, Wang L, Wang W, Lin J, Han J, Sun
H, Guo H, Sun R and Wu Q: TSC-36/FRP inhibits vascular smooth
muscle cell proliferation and migration. Exp Mol Pathol.
80:132–140. 2006. View Article : Google Scholar
|
|
12
|
Gawlitta D, van Rijen MHP, Schrijver EJM,
Alblas J and Dhert WJA: Hypoxia impedes hypertrophic chondrogenesis
of human multipotent stromal cells. Tissue Eng Part A.
18:1957–1966. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilson DC, Marinov AD, Blair HC, Bushnell
DS, Thompson SD, Chaly Y and Hirsch R: Follistatin-like protein 1
is a mesenchyme-derived inflammatory protein and may represent a
biomarker for systemic-onset juvenile rheumatoid arthritis.
Arthritis Rheum. 62:2510–2516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hayakawa S, Ohashi K, Shibata R, Kataoka
Y, Miyabe M, Enomoto T, Joki Y, Shimizu Y, Kambara T, Uemura Y, et
al: Cardiac Myocyte-derived Follistatin-like 1 prevents renal
injury in a subtotal nephrectomy model. J Am Soc Nephrol.
26:636–646. 2015. View Article : Google Scholar
|
|
15
|
Widera C, Horn-Wichmann R, Kempf T,
Bethmann K, Fiedler B, Sharma S, Lichtinghagen R, Leitolf H,
Ivandic B, Katus HA, et al: Circulating concentrations of
Follistatin-like 1 in healthy individuals and patients with acute
coronary syndrome as assessed by an immunoluminometric sandwich
assay. Clin Chem. 55:1794–1800. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shimano M, Ouchi N, Nakamura K, van Wijk
B, Ohashi K, Asaumi Y, Higuchi A, Pimentel DR, Sam F, Murohara T,
et al: Cardiac myocyte follistatin-like 1 functions to attenuate
hypertrophy following pressure overload. Proc Natl Acad Sci USA.
108:E899–E906. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mattiotti A, Prakash S, Barnett P and van
den Hoff MJB: Follistatin-like 1 in development and human diseases.
Cell Mol Life Sci. 75:2339–2354. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murphy N, Gaynor KU, Rowan SC, Walsh SM,
Fabre A, Boylan J, Keane MP and McLoughlin P: Altered expression of
bone morphogenetic protein accessory proteins in murine and human
pulmonary fibrosis. Am J Pathol. 186:600–615. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chaly Y, Fu Y, Marinov A, Hostager B, Yan
W, Campfield B, Kellum JA, Bushnell D, Wang Y, Vockley J and Hirsch
R: Follistatin-like protein 1 enhances NLRP3 inflammasome-mediated
IL-1β secretion from monocytes and macrophages. Eur J Immunol.
44:1467–1479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sundaram GM, Common JE, Gopal FE, Srikanta
S, Lakshman K, Lunny DP, Lim TC, Tanavde V, Lane EB and Sampath P:
'See-saw' expression of microRNA-198 and FSTL1 from a single
transcript in wound healing. Nature. 495:103–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ogura Y, Ouchi N, Ohashi K, Shibata R,
Kataoka Y, Kambara T, Kito T, Maruyama S, Yuasa D, Matsuo K, et al:
Therapeutic impact of Follistatin-like 1 on myocardial ischemic
injury in preclinical models. Circulation. 126:1728–1738. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Armouche A, Ouchi N, Tanaka K, Doros G,
Wittköpper K, Schulze T, Eschenhagen T, Walsh K and Sam F:
Follistatin-like 1 in chronic systolic heart failure: A marker of
left ventricular remodeling. Circ Heart Fail. 4:621–627. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaly Y, Hostager B, Smith S and Hirsch R:
Follistatin-like protein 1 and its role in inflammation and
inflammatory diseases. Immunol Res. 59:266–272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Torres S, Bartolomé RA, Mendes M, Barderas
R, Fernandez-Aceñero MJ, Peláez-García A, Peña C, Lopez-Lucendo M,
Villar-Vázquez R, de Herreros AG, et al: Proteome profiling of
Cancer-associated fibroblasts identifies novel proinflammatory
signatures and prognostic markers for colorectal cancer. Clin
Cancer Res. 19:6006–6019. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou X, Xiao X, Huang T, Du C, Wang S, Mo
Y, Ma N, Murata M, Li B, Wen W, et al: Epigenetic inactivation of
follistatin-like 1 mediates tumor immune evasion in nasopharyngeal
carcinoma. Oncotarget. 7:16433–16444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Tan X, Liu W, Chen X, Hou X, Shen
D, Ding Y, Yin J, Wang L, Zhang H, et al: Follistatin-like protein
1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
Chin J Cancer. 37:22018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li L, Huang S, Yao Y, Chen J, Li J, Xiang
X, Deng J and Xiong J: Follistatin-like 1 (FSTL1) is a prognostic
biomarker and correlated with immune cell infiltration in gastric
cancer. World J Surg Oncol. 18:3242020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li G, Ren H, Wu X, Hu Q, Hong Z, Wang G,
Gu G, Ren J and Li J: Follistatin like protein-1 modulates
macrophage polarization and aggravates dextran sodium
sulfate-induced colitis. Int Immunopharmacol. 83:1064562020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Wang Y, Zheng G, Liu Y, Li J,
Huang H, Xu C, Zeng Y, Zhang X, Qin J, et al: Follistatin-like 1
(FSTL1) interacts with Wnt ligands and Frizzled receptors to
enhance Wnt/β-catenin signaling in obstructed kidneys in vivo. J
Biol Chem. 298:1020102022. View Article : Google Scholar
|
|
30
|
Zheng X, Zhou X, Ma G, Yu J, Zhang M, Yang
C, Hu Y, Ma S, Han Z, Ning W, et al: Endogenous Follistatin-like 1
guarantees the immunomodulatory properties of mesenchymal stem
cells during liver fibrotic therapy. Stem Cell Res Ther.
13:4032022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei
S, Liu M, Wang P, Qiu J, Zhang L, et al: FSTL1 promotes liver
fibrosis by reprogramming macrophage function through modulating
the intracellular function of PKM2. Gut. 71:2539–2550. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu T, Liu Y, Miller M, Cao L, Zhao J, Wu
J, Wang J, Liu L, Li S, Zou M, et al: Autophagy plays a role in
FSTL1-induced epithelial mesenchymal transition and airway
remodeling in asthma. Am J Physiol Lung Cell Mol Physiol.
313:L27–L40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin YK, Li XH, Wang W, Liu J, Zhang W,
Fang YS, Zhang ZF, Dai HP, Ning W and Wang C: Follistatin-Like 1
Promotes Bleomycin-induced pulmonary fibrosis through the
transforming growth factor beta 1/Mitogen-activated protein kinase
signaling pathway. Chin Med J (Engl). 131:1917–1925. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Murakami K, Tanaka M, Usui T, Kawabata D,
Shiomi A, Iguchi-Hashimoto M, Shimizu M, Yukawa N, Yoshifuji H,
Nojima T, et al: Follistatin-related protein/follistatin-like 1
evokes an innate immune response via CD14 and toll-like receptor 4.
FEBS Lett. 586:319–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao X, Zhang H, Ning W, Yang Z, Wang Y
and Zhang T: Knockdown of FSTL1 inhibits microglia activation and
alleviates depressive-like symptoms through modulating
TLR4/MyD88/NF-κB pathway in CUMS mice. Exp Neurol. 353:1140602022.
View Article : Google Scholar
|
|
36
|
Chaly Y, Hostager B, Smith S and Hirsch R:
The Follistatin-like protein 1 pathway is important for maintaining
healthy articular cartilage. ACR Open Rheumatol. 2:407–414. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li W, Alahdal M, Deng Z, Liu J, Zhao Z,
Cheng X, Chen X, Li J, Yin J, Li Y, et al: Molecular functions of
FSTL1 in the osteoarthritis. Int Immunopharmacol. 83:1064652020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tanaka K, Valero-Muñoz M, Wilson RM,
Essick EE, Fowler CT, Nakamura K, van den Hoff M, Ouchi N and Sam
F: Follistatin-Like 1 regulates hypertrophy in heart failure with
preserved ejection fraction. JACC Basic Transl Sci. 1:207–221.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Prakash S, Borreguero LJJ, Sylva M, Flores
Ruiz L, Rezai F, Gunst QD, de la Pompa JL, Ruijter JM and van den
Hoff MJB: Deletion of fstl1 (Follistatin-Like 1) From the
Endocardial/Endothelial lineage causes mitral valve disease.
Arterioscler Thromb Vasc Biol. 37:e116–e130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chaly Y, Blair HC, Smith SM, Bushnell DS,
Marinov AD, Campfield BT and Hirsch R: Follistatin-like protein 1
regulates chondrocyte proliferation and chondrogenic
differentiation of mesenchymal stem cells. Ann Rheum Dis.
74:1467–1473. 2015. View Article : Google Scholar
|
|
41
|
Ouchi N, Oshima Y, Ohashi K, Higuchi A,
Ikegami C, Izumiya Y and Walsh K: Follistatin-like 1, a secreted
muscle protein, promotes endothelial cell function and
revascularization in ischemic tissue through a Nitric-oxide
Synthase-dependent mechanism. J Biol Chem. 283:32802–32811. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu S, Yang Y, Jiang S, Xu H, Tang N, Lobo
A, Zhang R, Liu S, Yu T and Xin H: MiR-378a-5p Regulates
proliferation and migration in vascular smooth muscle cell by
targeting CDK1. Front Genet. 10:222019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hambrock HO, Kaufmann B, Müller S, Hanisch
FG, Nose K, Paulsson M, Maurer P and Hartmann U: Structural
characterization of TSC-36/Flik: Analysis of two charge isoforms. J
Biol Chem. 279:11727–11735. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yan X, Ding JY, Zhang RJ, Wang YX, Zhou
LP, Zhang HQ, Kang L, Jia CY, Liu XY and Shen CL: FSTL1 accelerates
nucleus Pulposus-derived mesenchymal stem cell apoptosis in
intervertebral disc degeneration by activating TGF-β-mediated
Smad2/3 phosphorylation. J Transl Med. 23:2322025. View Article : Google Scholar
|
|
45
|
Javaheri B, Poulet B, Aljazzar A, de Souza
R, Piles M, Hopkinson M, Shervill E, Pollard A, Chan B, Chang YM,
et al: Stable sulforaphane protects against gait anomalies and
modifies bone microarchitecture in the spontaneous STR/Ort model of
osteoarthritis. Bone. 103:308–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rosas IO, Richards TJ, Konishi K, Zhang Y,
Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo
A, et al: MMP1 and MMP7 as potential peripheral blood biomarkers in
idiopathic pulmonary fibrosis. PLoS Med. 5:e932008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I
and Yu Q: Inhibition of the hyaluronan-CD44 interaction by merlin
contributes to the tumor-suppressor activity of merlin. Oncogene.
26:836–850. 2007. View Article : Google Scholar
|
|
48
|
Gorelik L, Gilbride K, Dobles M, Kalled
SL, Zandman D and Scott ML: Normal B cell homeostasis requires B
cell activation factor production by Radiation-resistant cells. J
Exp Med. 198:937–945. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang XH, Chen Y, Li B, Liu JY, Yang CM
and Ma MZ: Blocking follistatin-like 1 attenuates liver fibrosis in
mice by regulating transforming growth factor-beta signaling. Int J
Clin Exp Pathol. 11:1112–1122. 2018.PubMed/NCBI
|
|
50
|
Song CAL, Adili A, Kari A and Abuduhaer A:
FSTL1 aggravates sepsis-induced acute kidney injury through
regulating TLR4/MyD88/NF-κB pathway in newborn rats. Signa Vitae.
17:167–173. 2021.
|
|
51
|
Bevivino G, Sedda S, Franzè E, Stolfi C,
Di Grazia A, Dinallo V, Caprioli F, Facciotti F, Colantoni A,
Ortenzi A, et al: Follistatin-like protein 1 sustains colon cancer
cell growth and survival. Oncotarget. 9:31278–31290. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Karisa P, Sylviana N, Fitria N and
Setiawan S: FSTL-1 as a novel cardiokine of cardiac angiogenesis: A
systematic review. Vasc Health Risk Manag. 21:437–449. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xi Y, Hao M, Liang Q, Li Y, Gong DW and
Tian Z: Dynamic resistance exercise increases skeletal
muscle-derived FSTL1 inducing cardiac angiogenesis via
DIP2A-Smad2/3 in rats following myocardial infarction. J Sport
Health Sci. 10:594–603. 2021. View Article : Google Scholar :
|
|
54
|
Alteköester AK and Harvey RP:
Bioengineered FSTL1 patches restore cardiac function following
myocardial infarction. Trends Mol Med. 21:731–733. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kon M, Ebi Y and Nakagaki K: Effects of
acute sprint interval exercise on Follistatin-like 1 and apelin
secretions. Arch Physiol Biochem. 127:223–227. 2021. View Article : Google Scholar
|
|
56
|
Shang H, Liu X and Guo H: Knockdown of
Fstl1 attenuates hepatic stellate cell activation through the
TGF-β1/Smad3 signaling pathway. Mol Med Rep. 16:7119–7123. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zheng X, Qi C, Zhang S, Fang Y and Ning W:
TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung
fibroblasts. Am J Physiol Lung Cell Mol Physiol. 313:L240–L251.
2017. View Article : Google Scholar
|
|
58
|
Sylva M, Moorman AF and van den Hoff MJB:
Follistatin-like 1 in vertebrate development. Birth Defects Res C
Embryo Today. 99:61–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Talavera-Adame D, Wu G, He Y, Ng TT, Gupta
A, Kurtovic S, Hwang JY, Farkas DL and Dafoe DC: Endothelial cells
in co-culture enhance embryonic stem cell differentiation to
pancreatic progenitors and insulin-producing cells through BMP
signaling. Stem Cell Rev Rep. 7:532–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li W, Chi Y, Xiao X, Li J, Sun M, Sun S,
Xu W, Zhang L, Li X, Cheng F, et al: Plasma FSTL-1 as a noninvasive
diagnostic biomarker for patients with advanced liver fibrosis.
Hepatology. 82:669–682. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tang Y, Ke Y and Ma H: Non-invasive
assessment techniques for renal fibrosis: Advances and
perspectives. Ren Fail. 47:25556852025. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Du R, Li K, Guo K, Chen Z, Han L and Bian
H: FSTL1: A double-edged sword in cancer development. Gene.
906:1482632024. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li X, Fang Y, Jiang D, Dong Y, Liu Y,
Zhang S, Guo J, Qi C, Zhao C, Jiang F, et al: Targeting FSTL1 for
multiple fibrotic and systemic autoimmune diseases. Mol Ther.
29:347–364. 2021. View Article : Google Scholar
|
|
64
|
Xu XY, Du Y, Liu X, Ren Y, Dong Y, Xu HY,
Shi JS, Jiang D, Xu X, Li L, et al: Targeting follistatin like 1
ameliorates liver fibrosis induced by carbon tetrachloride through
TGF-β1-miR29a in mice. Cell Commun Signal. 18:1512020. View Article : Google Scholar
|
|
65
|
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M,
Zeng C, Zhou T and Zhang J: NF-κB in biology and targeted therapy:
New insights and translational implications. Signal Transduct
Target Ther. 9:532024. View Article : Google Scholar
|
|
66
|
Mussbacher M, Derler M, Basílio J and
Schmid JA: NF-κB in monocytes and macrophages-an inflammatory
master regulator in multitalented immune cells. Front Immunol.
14:11346612023. View Article : Google Scholar
|
|
67
|
Niu Z, Guo J, Liu X, Chen M, Jin Y, Yao M,
Li X, Che Q, Li S, Zhang C, et al: Renal tubular epithelial-derived
follistatin-like 1 protects against UUO-induced renal fibrosis in
mice via inhibiting NF-κB-mediated epithelial inflammation.
Theranostics. 15:2413–2427. 2025. View Article : Google Scholar
|
|
68
|
Lan Y, Dong C, Wu M, Yuan R, Yang K, Yang
Z, Chen Y, Zhang J, Qi B and Lu X: Quercetin ameliorates
epithelial-mesenchymal transition and inflammation by targeting
FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis. Front
Pharmacol. 16:15947572025. View Article : Google Scholar
|
|
69
|
Chen L and Liu Z: Downregulation of FSTL-1
attenuates the inflammation injury during Streptococcus pneumoniae
infection by inhibiting the NLRP3 and TLR4/NF-κB signaling pathway.
Mol Med Rep. 20:5345–5352. 2019.PubMed/NCBI
|
|
70
|
Yang Q, Guo W, Wang L, Zhang Y, Tian Y,
Ming D, Xiao X and Yang J: Effects of Fstl1 on neuroinflammation
and microglia activation in lipopolysaccharide-induced acute
depression-like mice. Behav Brain Res. 493:1156962025. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang B, Geng H, Zhao K, Omorou M, Liu S,
Ye Z, Zhang F, Luan H and Zhang X: FSTL1 aggravates high
Glucose-induced oxidative stress and transdifferentiation in HK-2
cells. Sci Rep. 15:4342025. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Fan N, Sun H, Wang Y, Wang Y, Zhang L, Xia
Z, Peng L, Hou Y, Shen W, Liu R, et al: Follistatin-like 1: A
potential mediator of inflammation in obesity. Mediators Inflamm.
2013:7525192013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Parola M: Follistatin-like protein 1 and
chronic liver disease progression: A novel pro-inflammatory and
pro-fibrogenic mediator? J Hepatol. 75:1014–1016. 2021.
|
|
74
|
Ni X, Cao X, Wu Y and Wu J: FSTL1
suppresses tumor cell proliferation, invasion and survival in
non-small cell lung cancer. Oncol Rep. 39:13–20. 2018.
|
|
75
|
Dai D, Xie J, Zheng Y, Chen F, Zhao B and
Miao L: H3K27 acetylation-induced FSTL1 upregulation by P300/RUNX1
co-activation exacerbated autophagy-mediated neuronal damage and
NF-κB-stimulated inflammation in Alzheimer's disease.
Cytotechnology. 75:449–460. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Cao H, Han X, Jia Y and Zhang B:
Inhibition of long non-coding RNA HOXA11-AS against
neuroinflammation in Parkinson's disease model via targeting
miR-124-3p mediated FSTL1/NF-κB axis. Aging (Albany NY).
13:11455–11469. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Velikova T, Bakopoulou K, Gulinac M,
Manova E, Valkov H, Miteva D and Shumnalieva R: Emerging
therapeutic and inflammation biomarkers: The role of Meteorin-Like
(Metrnl) and Follistatin-Like 1 (FSTL1) in inflammatory diseases.
Int J Mol Sci. 26:97112025. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kudo-Saito C, Ishida A, Shouya Y, Teramoto
K, Igarashi T, Kon R, Saito K, Awada C, Ogiwara Y and Toyoura M:
Blocking the FSTL1-DIP2A Axis Improves Anti-tumor immunity. Cell
Rep. 24:1790–1801. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lau MC, Ng KY, Wong TL, Tong M, Lee TK,
Ming XY, Law S, Lee NP, Cheung AL, Qin YR, et al: FSTL1 promotes
metastasis and chemoresistance in esophageal squamous cell
carcinoma through NFκB-BMP signaling Cross-talk. Cancer Res.
77:5886–5899. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Qu Y, Liu Y and Li R: FSTL1 promotes
inflammatory reaction and cartilage catabolism through interplay
with NFκB signaling pathways in an in vitro ONFH Model.
Inflammation. 42:1491–1503. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Santos L, Guggeri L, Escande C, Badano JL
and Prieto-Echagüe V: FSTL1 is an antagonist of ERK1/2
phosphorylation during ciliogenesis and preadipocyte
differentiation. bioRxiv. Feb 21–2024.Epub ahead of print.
View Article : Google Scholar
|
|
82
|
Liu Z, Zhang H and Hu X: Analysis of the
expression and mechanism of follistatin-like protein 1 in cervical
cancer. Oncol Rep. 50:2152023. View Article : Google Scholar
|
|
83
|
Zhang Y, Xu X, Yang Y, Ma J, Wang L, Meng
X, Chen B, Qin L, Lu T and Gao Y: Deficiency of Follistatin-like
protein 1 accelerates the growth of breast cancer cells at lung
metastatic sites. J Breast Cancer. 21:267–276. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Kuna J, Chmielewski G, Jaśkiewicz Ł,
Knapik M and Krajewska-Włodarczyk M: The role of selected myokines
in the development of cardiovascular diseases, and their
involvement in developing heart failure in rheumatoid arthritis
patients. Int J Mol Sci. 26:81942025. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Xu C, Jiang T, Ni S, Chen C, Li C, Zhuang
C, Zhao G, Jiang S, Wang L, Zhu R, et al: FSTL1 promotes nitric
oxide-induced chondrocyte apoptosis via activating the
SAPK/JNK/caspase3 signaling pathway. Gene. 732:1443392020.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Le Luduec JB, Condamine T, Louvet C,
Thebault P, Heslan JM, Heslan M, Chiffoleau E and Cuturi MC: An
immunomodulatory role for Follistatin-like 1 in heart allograft
transplantation. Am J Transplant. 8:2297–2306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Horak M, Fairweather D, Kokkonen P, Bednar
D and Bienertova-Vasku J: Follistatin-like 1 and its paralogs in
heart development and cardiovascular disease. Heart Fail Rev.
27:2251–2265. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang S, Wei J, Shi J, He Q, Zhou X, Gao X
and Cheng L: Follistatin-like 1 attenuation suppresses
intervertebral disc degeneration in mice through interacting with
TNF-α and Smad signaling pathway. Oxid Med Cell Longev.
2021:66407512021. View Article : Google Scholar
|
|
89
|
Kim HJ, Kang WY, Seong SJ, Kim SY, Lim MS
and Yoon YR: Follistatin-like 1 promotes osteoclast formation via
RANKL-mediated NF-κB activation and M-CSF-induced precursor
proliferation. Cell Signal. 28:1137–1144. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Guo J, Liang W, Li J and Long J: Knockdown
of FSTL1 inhibits oxLDL-induced inflammation responses through the
TLR4/MyD88/NF-κB and MAPK pathway. Biochem Biophys Res Commun.
478:1528–1533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yang W, Wu Y, Wang C, Liu Z, Xu M and
Zheng X: FSTL1 contributes to tumor progression via attenuating
apoptosis in a AKT/GSK-3β-dependent manner in hepatocellular
carcinoma. Cancer Biomark. 20:75–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Shen H, Cui G, Li Y, Ye W, Sun Y, Zhang Z,
Li J, Xu G, Zeng X, Zhang Y, et al: Follistatin-like 1 protects
mesenchymal stem cells from hypoxic damage and enhances their
therapeutic efficacy in a mouse myocardial infarction model. Stem
Cell Res Ther. 10:172019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ou M, Li C, Tang D, Xue W, Xu Y, Zhu P, Li
B, Xie J, Chen J, Sui W, et al: Genotyping, generation and
proteomic profiling of the first human autosomal dominant
osteopetrosis type II-specific induced pluripotent stem cells. Stem
Cell Res Ther. 10:2512019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Rodrigues Gomes J: A narrative review on
the FSTL-1 protein and its current known impact on cardiovascular
ischaemic disease. Int J Med Students. 12:457–464. 2024. View Article : Google Scholar
|
|
95
|
Liang X, Hu Q, Li B, McBride D, Bian H,
Spagnoli P, Chen D, Tang J and Zhang JH: Follistatin-like 1
attenuates apoptosis via disco-interacting protein 2 homolog A/Akt
pathway after middle cerebral artery occlusion in rats. Stroke.
45:3048–3054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Oshima Y, Ouchi N, Sato K, Izumiya Y,
Pimentel DR and Walsh K: Follistatin-like 1 is an Akt-regulated
cardioprotective factor secreted by the heart. Circ Res.
103:337–346. 2008.
|
|
97
|
Han YB, Zhou G, Zheng SF, Li G and Zhao T:
Follistatin-like protein 1 promotes mechanical ventilation-induced
NLRP3 inflammasome activation in human pulmonary microvascular
endothelial cells. Inflamm Res. 72:311–323. 2023.
|
|
98
|
Wang L, Wang N, Shi G and Sun S:
Follistatin-like 1 ameliorates severe acute pancreatitis associated
lung injury via inhibiting the activation of NLRP3 inflammasome and
NF-κB pathway. Am J Transl Res. 14:4310–4320. 2022.
|
|
99
|
Fang Y, Zhang S, Li X, Jiang F, Ye Q and
Ning W: Follistatin like-1 aggravates silica-induced mouse lung
injury. Sci Rep. 7:3992017. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhou H, Wang L, Lv W and Yu H: The NLRP3
inflammasome in allergic diseases: Mechanisms and therapeutic
implications. Clin Exp Med. 24:2312024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Ramachandran R, Manan A, Kim J and Choi S:
NLRP3 inflammasome: A key player in the pathogenesis of life-style
disorders. Exp Mol Med. 56:1488–1500. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang Y and Xia Y: Mon-210 Role of
follistatin-like1 (Fstl1) in chronic kidney disease. Kidney Int
Rep. 4(Suppl 1): S3872019. View Article : Google Scholar
|
|
103
|
Zhao Y, Sun J, Zhang W, et al:
Follistatin-like 1 protects against doxorubicin-induced
cardiomyopathy through upregulation of Nrf2. Free Radic Biol Med.
195:164–176. 2023.
|
|
104
|
Casey AM, Ryan DG, Prag HA, Chowdhury SR,
Marques E, Turner K, Gruszczyk AV, Yang M, Wolf DM, Miljkovic JL,
et al: Pro-inflammatory macrophages produce mitochondria-derived
superoxide by reverse electron transport at complex I that
regulates IL-1β release during NLRP3 inflammasome activation. Nat
Metab. 7:493–507. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Marques E, Kramer R and Ryan DG:
Multifaceted mitochondria in innate immunity. NPJ Metab Health Dis.
2:62024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhang Y, Zou M, Wu H, Zhu J and Jin T: The
cGAS-STING pathway drives neuroinflammation and neurodegeneration
via cellular and molecular mechanisms in neurodegenerative
diseases. Neurobiol Dis. 202:1067102024. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Li K, Zhang W, Niu L, Ye Y, Ren J and Liu
C: Lead-free cesium manganese halide nanocrystals embedded glasses
for X-Ray imaging. Adv Sci (Weinh). 10:e22048432023. View Article : Google Scholar :
|
|
108
|
Wang J, Zhuang H, Jia L, He X, Zheng S, Ji
K, Xie K, Ying T, Zhang Y, Li C and Chang X: Nuclear receptor
subfamily 4 group A member 1 promotes myocardial
ischemia/reperfusion injury through inducing mitochondrial fission
factor-mediated mitochondrial fragmentation and inhibiting FUN14
domain containing 1-depedent mitophagy. Int J Biol Sci.
20:4458–4475. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Chang X, Zhou S, Liu J, Wang Y, Guan X, Wu
Q, Liu Z and Liu R: Zishenhuoxue decoction-induced myocardial
protection against ischemic injury through TMBIM6-VDAC1-mediated
regulation of calcium homeostasis and mitochondrial quality
surveillance. Phytomedicine. 132:1553312024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Pang B, Dong G, Pang T, Sun X, Liu X, Nie
Y and Chang X: Emerging insights into the pathogenesis and
therapeutic strategies for vascular endothelial injury-associated
diseases: Focus on mitochondrial dysfunction. Angiogenesis.
27:623–639. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Chang X, Zhang Q, Huang Y, Liu J, Wang Y,
Guan X, Wu Q, Liu Z and Liu R: Quercetin inhibits necroptosis in
cardiomyocytes after ischemia-reperfusion via
DNA-PKcs-SIRT5-orchestrated mitochondrial quality control.
Phytother Res. 38:2496–2517. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Pu X, Zhang Q, Liu J, Wang Y, Guan X, Wu
Q, Liu Z, Liu R and Chang X: Ginsenoside Rb1 ameliorates heart
failure through DUSP-1-TMBIM-6-mediated mitochondrial quality
control and gut flora interactions. Phytomedicine. 132:1558802024.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Li MY, Gao RP, Zhu Q, Chen Y, Tao BB and
Zhu YC: Skeletal muscle-derived FSTL1 starting up angiogenesis by
regulating endothelial junction via activating Src pathway can be
upregulated by hydrogen sulfide. Am J Physiol Cell Physiol.
325:C1252–C1266. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Garcia D and Shaw RJ: AMPK: Mechanisms of
cellular energy sensing and restoration of metabolic balance. Mol
Cell. 66:789–800. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Seki M, Powers JC, Maruyama S, Zuriaga MA,
Wu CL, Kurishima C, Kim L, Johnson J, Poidomani A, Wang T, et al:
Acute and chronic increases of circulating FSTL1 normalize energy
substrate metabolism in Pacing-induced heart failure. Circ Heart
Fail. 11:e0044862018. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Wang N, Wang B, Maswikiti EP, Yu Y, Song
K, Ma C, Han X, Ma H, Deng X, Yu R and Chen H: AMPK-a key factor in
crosstalk between tumor cell energy metabolism and immune
microenvironment? Cell Death Discov. 10:2372024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Li JP, He WB, Xu SW, Liu JZ, Huang ZQ, Li
CP, Huang CL, Mai PB, Geng DF, Qiu XF, et al: FSTL1 protects
against acute aortic dissection by suppressing vascular smooth
muscle cell phenotypic switching and degradation of the
extracellular matrix. J Mol Cell Cardiol. 198:60–73. 2025.
View Article : Google Scholar
|
|
118
|
Tania NP, Maarsingh H, Bos IS, Mattiotti
A, Prakash S, Timens W, Gunst QD, Jimenez-Borreguero LJ, Schmidt M,
van den Hoff MJB and Gosens R: Endothelial follistatin-like-1
regulates the postnatal development of the pulmonary vasculature by
modulating BMP/Smad signaling. Pulm Circ. 7:219–231. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Ahsan M, Garneau L and Aguer C: The
bidirectional relationship between AMPK pathway activation and
myokine secretion in skeletal muscle: How it affects energy
metabolism. Front Physiol. 13:10408092022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Lee HJ, Lee JO, Lee YW, Kim SA, Park SH
and Kim HS: Kalirin, a GEF for Rac1, plays an important role in
FSTL-1-mediated glucose uptake in skeletal muscle cells. Cell
Signal. 29:150–157. 2017. View Article : Google Scholar
|
|
121
|
Chen J, Zong J, Su S, Ji X, Wang L, Han X
and Zhao M: Cardiovascular system is influenced by skeletal
Muscle-derived extracellular vesicles, myokines and MicroRNAs based
on inter-organ communication: A systematic review. Int J Med Sci.
22:2382–2397. 2025. View Article : Google Scholar
|
|
122
|
Dong Y, Geng Y, Li L, Li X, Yan X, Fang Y,
Li X, Dong S, Liu X, Li X, et al: Blocking follistatin-like 1
attenuates bleomycin-induced pulmonary fibrosis in mice. J Exp Med.
212:235–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Ni S, Miao K, Zhou X, Xu N, Li C, Zhu R,
Sun R and Wang Y: The involvement of follistatin-like protein 1 in
osteoarthritis by elevating NF-κB-mediated inflammatory cytokines
and enhancing fibroblast like synoviocyte proliferation. Arthritis
Res Ther. 17:912015. View Article : Google Scholar
|
|
124
|
Miyamae T, Marinov AD, Sowders D, Wilson
DC, Devlin J, Boudreau R, Robbins P and Hirsch R: Follistatin-like
Protein-1 is a novel proinflammatory molecule. J Immunol.
177:4758–4762. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wang Y, Li D, Xu N, Tao W, Zhu R, Sun R,
Fan W, Zhang P, Dong T and Yu L: Follistatin-like protein 1: A
serum biochemical marker reflecting the severity of joint damage in
patients with osteoarthritis. Arthritis Res Ther. 13:R1932011.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li D, Wang Y, Xu N, Wei Q, Wu M, Li X,
Zheng P, Sun S, Jin Y, Zhang G, et al: Follistatin-like protein 1
is elevated in systemic autoimmune diseases and correlated with
disease activity in patients with rheumatoid arthritis. Arthritis
Res Ther. 13:R172011. View
Article : Google Scholar : PubMed/NCBI
|
|
127
|
Parfenova OK, Kukes VG and Grishin DV:
Follistatin-like proteins: Structure, functions and biomedical
importance. Biomedicines. 9:9992021. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
796. Suppression of collagen-induced
arthritis by neutralizing follistatin-like protein-1. Mol Ther.
16(Suppl 1): S2982008. View Article : Google Scholar
|
|
129
|
Taina-González L and de la Fuente M: The
potential of nanomedicine to unlock the limitless applications of
mRNA. Pharmaceutics. 14:4602022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Evers MJW, Du W, Yang Q, Kooijmans SAA,
Vink A, van Steenbergen M, Vader P, de Jager SCA, Fuchs SA,
Mastrobattista E, et al: Delivery of modified mRNA to damaged
myocardium by systemic administration of lipid nanoparticles. J
Control Release. 343:207–216. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Liu C, Kong N, Liu H, Zhang Y, Qin W, Zhao
W, Yang X, Wang Y, Cao X, Liu T, et al: FSTL1 and TLR4 interact
with PEDV structural proteins to promote virus adsorption to host
cells. J Virol. 99:e01837242025. View Article : Google Scholar :
|
|
132
|
Nakamura K: Key mediators of the efficacy
of mesenchymal stem cells on in vivo disease models. Cell
Transplant. Jun 25–2025.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Chaly Y, Smith S, Bushnell D, Campfield B,
Blair H and Hirsch R: Follistatin-like protein 1 is an important
regulator of chondrogenesis. In: 2013 ACR/ARHP Annual Meeting; 66.
2013
|
|
134
|
Zheng X, Tian S, Li T, Zhang S, Zhou X,
Liu Y, Su R, Zhang M, Li B, Qi C, et al: Host FSTL1 defines the
impact of stem cell therapy on liver fibrosis by potentiating the
early recruitment of inflammatory macrophages. Signal Transduct
Target Ther. 10:812025. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Wu Y, Zhou S and Smas CM: Downregulated
expression of the secreted glycoprotein follistatin-like 1 (Fstl1)
is a robust hallmark of preadipocyte to adipocyte conversion. Mech
Dev. 127:183–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Li F, Qian W, Wang J and Gao M: FSTL1 can
be a promising target in TMJ osteoarthritis via regulating
chondrocyte mitophagy and apoptosis. J Craniofac Surg.
36:1401–1407. 2025. View Article : Google Scholar :
|
|
137
|
Melas IN, Chairakaki AD, Chatzopoulou EI,
Messinis DE, Katopodi T, Pliaka V, Samara S, Mitsos A, Dailiana Z,
Kollia P and Alexopoulos LG: Modeling of signaling pathways in
chondrocytes based on phosphoproteomic and cytokine release data.
Osteoarthritis Cartilage. 22:509–518. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Jia S, Yu Z and Bai L: Exerkines and
osteoarthritis. Front Physiol. 14:13027692023. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Liu Y, Xu J, Liu T, Wu J, Zhao J, Wang J,
Zou M, Cao L, Liu X, Pan Y, et al: FSTL1 aggravates cigarette
smoke-induced airway inflammation and airway remodeling by
regulating autophagy. BMC Pulm Med. 21:452021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Campfield BT, Eddens T, Henkel M, Majewski
M, Horne W, Chaly Y, Gaffen SL, Hirsch R and Kolls JK:
Follistatin-like protein 1 modulates IL-17 signaling via IL-17RC
regulation in stromal cells. Immunol Cell Biol. 95:656–665. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Sisto M, Ribatti D, Ingravallo G and Lisi
S: The expression of Follistatin-like 1 protein is associated with
the activation of the EMT program in Sjögren's syndrome. J Clin
Med. 11:53682022. View Article : Google Scholar
|
|
142
|
Hwang B, Korsnick L, Shen M, Jin L, Singh
Y, Abdalla M, Bauser-Heaton H and Serpooshan V: FSTL-1 loaded 3D
bioprinted vascular patch regenerates the ischemic heart tissue.
iScience. 27:1107702024. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Wang X, Wu DH and Senyo SE: mRNA therapy
for myocardial infarction: A review of targets and delivery
vehicles. Front Bioeng Biotechnol. 10:10370512022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Fang D, Shi X, Lu T, Ruan H and Gao Y: The
glycoprotein follistatin-like 1 promotes brown adipose
thermogenesis. Metabolism. 98:16–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Lang H, Zhang H, Ma M, Wan X, Chen Y, Sun
Q and Cao C: Serum Fstl1, a novel biomarker screened based on
protein array technology, predict acute kidney injury and major
renal adverse events after cardiac surgery: A prospective cohort
study. Clin Chim Acta. 539:79–86. 2023. View Article : Google Scholar
|
|
146
|
Kim DK, Kang SH, Kim JS, Kim YG, Lee YH,
Lee DY, Ahn SY, Moon JY, Lee SH, Jeong KH and Hwang HS: Clinical
implications of circulating follistatin-like protein-1 in
hemodialysis patients. Sci Rep. 13:66372023. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Elsadek BEM, Abdelghany AA, Abd El-Aziz
MA, Madkor HR, Abd Elrady Ahmed A, Abd-Elghaffar SK and Elsadek
AAM: Validation of the diagnostic and prognostic values of ADAMTS5
and FSTL1 in osteoarthritis rat model. Cartilage. 13(2_Suppl):
1263S–1273S. 2021. View Article : Google Scholar
|
|
148
|
Geng Y, Dong Y, Yu M, Zhang L, Yan X, Sun
J, Qiao L, Geng H, Nakajima M, Furuichi T, et al: Follistatin-like
1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling
antagonist in controlling mouse lung development. Proc Natl Acad
Sci USA. 108:7058–7063. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Chen F, Hu Q, Huang H, Chen B, Xia Y and
Liu W: Follistatin-like protein 1 increases transepithelial
resistance in kidney epithelial cells through Akt signaling. Mol
Med Rep. 16:4341–4347. 2017. View Article : Google Scholar : PubMed/NCBI
|
